Reimbursement Support

To speak live with one of our Specialists, call (866) 681-3261 from 6 a.m.–5 p.m. PT, Monday to Friday, fax (866) 681-3288 or visit RituxanAccessSolutions.com

Indication

Rituxan^® (rituximab) in combination with methotrexate is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.

Rituxan is not recommended for treatment of patients with severe active infections.

Important Safety Information

Rituxan has been associated with fatal infusion reactions, tumor lysis syndrome (TLS), severe mucocutaneous reactions, and progressive multifocal leukoencephalopathy (PML)
Hepatitis B reactivation, cardiac arrhythmias, and angina have also been observed
Patients should be closely observed for signs of infection if biologic agents and/or DMARDs other than methotrexate are used concomitantly
Common adverse reactions include infusion reactions and infections

Please see full prescribing information, including Boxed Warnings for additional safety information.

Dedicated to patient access Print Page

Providing a broad range of programs to meet the diverse needs of your patients

Help your patients obtain the Rituxan therapy that you prescribe, regardless of their ability to pay. Learn more
The RITUXAN for RA EXPERIENCE Program:
Up to $4000 per 12-month period for new and current privately insured patients to cover co-pay costs for Rituxan. Learn more
Referrals for co-pay assistance:
Provides referrals for co-pay assistance to independent nonprofit organizations for privately or publicly insured patients. Learn more
Genentech^® Access to Care Foundation:
Free medicine for qualified uninsured or rendered uninsured Rituxan patients. Learn more

Coverage & Reimbursement

From benefits investigation to assistance with denials and appeals, Rituxan Access Solutions helps your office resolve coverage- and reimbursement-related issues

Coverage and benefit investigations
Prior authorization and recertification criteria
Denials and appeals
Answers to questions about coding and billing

Informational Resources

Rituxan Access Solutions provides additional services and information that may be of assistance to you if Rituxan for RA has been prescribed for one of your patients.

MyAccessSolutions online system
Glossary of access and reimbursement terms
Product spoilage and return information
Helpful online tutorials and Medicare/Medicaid search tools
Communication assistance services (translations, telephone-to-typewriter services)

Rituxan Access Solutions helps to resolve specific access and reimbursement issues for individual patients every day. Our dedicated specialists help bring patient treatment and practice solutions together.

Please visit www.RituxanAccessSolutions.com or contact Rituxan Access Solutions at 1-866-681-3261 for eligibility criteria for these financial assistance options.

: Rituxan and its logo are trademarks of Biogen Idec, Inc. Access Solutions^™ and its logo are trademarks of Genentech, Inc.

Next Section: Patient Access